385 related articles for article (PubMed ID: 33612147)
1. Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.
Monchatre-Leroy E; Lesellier S; Wasniewski M; Picard-Meyer E; Richomme C; Boué F; Lacôte S; Murri S; Pulido C; Vulin J; Salguero FJ; Gouilh MA; Servat A; Marianneau P
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33612147
[TBL] [Abstract][Full Text] [Related]
2. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection.
Everett HE; Lean FZX; Byrne AMP; van Diemen PM; Rhodes S; James J; Mollett B; Coward VJ; Skinner P; Warren CJ; Bewley KR; Watson S; Hurley S; Ryan KA; Hall Y; Simmons H; Núñez A; Carroll MW; Brown IH; Brookes SM
Viruses; 2021 Jan; 13(1):. PubMed ID: 33467732
[TBL] [Abstract][Full Text] [Related]
4. No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
Reed DS; McElroy AK; Barbeau DJ; McMillen CM; Tilston-Lunel NL; Nambulli S; Cottle E; Gilliland TC; Rannulu H; Lundy J; Olsen EL; O'Malley KJ; Xia M; Hartman AL; Luke TC; Egland K; Bausch C; Wu H; Sullivan EJ; Klimstra WB; Duprex WP
PLoS One; 2024; 19(6):e0290909. PubMed ID: 38900732
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
Proud PC; Tsitoura D; Watson RJ; Chua BY; Aram MJ; Bewley KR; Cavell BE; Cobb R; Dowall S; Fotheringham SA; Ho CMK; Lucas V; Ngabo D; Rayner E; Ryan KA; Slack GS; Thomas S; Wand NI; Yeates P; Demaison C; Zeng W; Holmes I; Jackson DC; Bartlett NW; Mercuri F; Carroll MW
EBioMedicine; 2021 Jan; 63():103153. PubMed ID: 33279857
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.
Kim YI; Yu KM; Koh JY; Kim EH; Kim SM; Kim EJ; Casel MAB; Rollon R; Jang SG; Song MS; Park SJ; Jeong HW; Kim EG; Lee OJ; Kim YD; Choi Y; Lee SA; Choi YJ; Park SH; Jung JU; Choi YK
Nat Commun; 2022 Jan; 13(1):21. PubMed ID: 35013229
[TBL] [Abstract][Full Text] [Related]
7. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
[TBL] [Abstract][Full Text] [Related]
8. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
[TBL] [Abstract][Full Text] [Related]
9. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling.
Bednash JS; Kagan VE; Englert JA; Farkas D; Tyurina YY; Tyurin VA; Samovich SN; Farkas L; Elhance A; Johns F; Lee H; Cheng L; Majumdar A; Jones D; Mejia OR; Ruane-Foster M; Londino JD; Mallampalli RK; Robinson RT
Transl Res; 2022 Feb; 240():1-16. PubMed ID: 34740873
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
Selvaraj P; Lien CZ; Liu S; Stauft CB; Nunez IA; Hernandez M; Nimako E; Ortega MA; Starost MF; Dennis JU; Wang TT
Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574037
[TBL] [Abstract][Full Text] [Related]
12. Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines.
Boley PA; Lee CM; Schrock J; Yadav KK; Patil V; Suresh R; Lu S; Feng MM; Hanson J; Channappanavar R; Kenney SP; Renukaradhya GJ
J Nanobiotechnology; 2023 Feb; 21(1):60. PubMed ID: 36814238
[TBL] [Abstract][Full Text] [Related]
13. Ferrets are valuable models for SARS-CoV-2 research.
Ciurkiewicz M; Armando F; Schreiner T; de Buhr N; Pilchová V; Krupp-Buzimikic V; Gabriel G; von Köckritz-Blickwede M; Baumgärtner W; Schulz C; Gerhauser I
Vet Pathol; 2022 Jul; 59(4):661-672. PubMed ID: 35001763
[TBL] [Abstract][Full Text] [Related]
14. Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.
Martins M; Fernandes MHV; Joshi LR; Diel DG
J Virol; 2022 Feb; 96(3):e0145521. PubMed ID: 34817200
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.
Ryan KA; Bewley KR; Fotheringham SA; Slack GS; Brown P; Hall Y; Wand NI; Marriott AC; Cavell BE; Tree JA; Allen L; Aram MJ; Bean TJ; Brunt E; Buttigieg KR; Carter DP; Cobb R; Coombes NS; Findlay-Wilson SJ; Godwin KJ; Gooch KE; Gouriet J; Halkerston R; Harris DJ; Hender TH; Humphries HE; Hunter L; Ho CMK; Kennard CL; Leung S; Longet S; Ngabo D; Osman KL; Paterson J; Penn EJ; Pullan ST; Rayner E; Skinner O; Steeds K; Taylor I; Tipton T; Thomas S; Turner C; Watson RJ; Wiblin NR; Charlton S; Hallis B; Hiscox JA; Funnell S; Dennis MJ; Whittaker CJ; Catton MG; Druce J; Salguero FJ; Carroll MW
Nat Commun; 2021 Jan; 12(1):81. PubMed ID: 33398055
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets.
Zumbrun EE; Zak SE; Lee ED; Bowling PA; Ruiz SI; Zeng X; Koehler JW; Delp KL; Bakken RR; Hentschel SS; Bloomfield HA; Ricks KM; Clements TL; Babka AM; Dye JM; Herbert AS
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140582
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
[TBL] [Abstract][Full Text] [Related]
19. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
20. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters.
Lee AC; Zhang AJ; Chan JF; Li C; Fan Z; Liu F; Chen Y; Liang R; Sridhar S; Cai JP; Poon VK; Chan CC; To KK; Yuan S; Zhou J; Chu H; Yuen KY
Cell Rep Med; 2020 Oct; 1(7):100121. PubMed ID: 32984855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
